Literature DB >> 6606433

Anti-Fab' antibodies in rheumatoid arthritis. Measurement of the relative quantities incorporated in soluble immune complexes in sera and supernatants from cultured peripheral blood lymphocytes.

H H Birdsall, M D Lidsky, R D Rossen.   

Abstract

High levels of anti-immunoglobulins that react with Fab' fragments of IgG have been observed in sera of patients with rheumatoid arthritis (RA). To determine how much of these anti-Fab' antibodies are incorporated within immune complexes (IC), we added 125I-Fab' to sera and then measured the amount of labeled Fab' that could be precipitated by adding polyethylene glycol (PEG). Sera were either maintained at neutral pH during this procedure or acidified (pH 3) to dissociate IC. Acidification permitted the 125I-Fab' an equal chance to compete with other endogenous antigens for anti-Fab' antibodies, once excess hydrogen ion was removed. Quantities of anti-Fab' in sera of 20 seropositive RA patients were greater than in sera of 43 age- and sex-matched healthy controls, as measured by this assay and by a solid phase radioimmunoassay. However, significantly less anti-Fab' antibody was incorporated in ICs in the RA patients' sera. Supernatants from cultured peripheral blood lymphocytes of RA patients also contained relatively more "free" and less "hidden" anti-Fab' than culture supernatants from controls. Thus there appear to be qualitative as well as quantitative differences in the anti-Fab' antibodies synthesized by RA patients. This may reflect different proportions of IgM and IgG anti-Fab' in their sera, differences in the average avidity of these antibodies, or differences in the reciprocal relationships within the idiotypic network that result in release of antibodies by certain antibody-producing cells, but not by clones that produce complementary idiotypes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606433     DOI: 10.1002/art.1780261210

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

Review 1.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

2.  Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome.

Authors:  J R Yu; E T Lennette; S Karpatkin
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

Review 3.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

4.  Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.

Authors:  F P Schena; A Pastore; N Ludovico; R A Sinico; S Benuzzi; V Montinaro
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

5.  Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae.

Authors:  D M Musher; A Goree; R E Baughn; H H Birdsall
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  Differences in anti-Fab antibodies in adult and late onset rheumatoid arthritis.

Authors:  F Gamerith; G J Zlabinger; O Scherak; G Kolarz; M Schemper; H Heinzl; J E Menzel
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

7.  Induction of an anti-Fab, anti-DNA and anti-RNA polymerase I autoantibody response network in rabbits immunized with SLE anti-DNA antibody.

Authors:  E Rombach; D A Stetler; J C Brown
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

8.  Family distribution of anti-F(ab')2 antibodies in relatives of patients with systemic lupus erythematosus.

Authors:  F Silvestris; R P Searles; A D Bankhurst; R C Williams
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  Rheumatoid factor (RF) distribution in periodontal disease.

Authors:  J Thé; J L Ebersole
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

10.  Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.

Authors:  J E Persselin; R H Stevens
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.